A higher CD8+/FOXP3+ ratio was observed by Liu et al. in the peritumoral area of non-luminal breast cancers and indicated greater cytolytic potential of the lymphocytic milieu surrounding these tumors [23]. Here, FOXP3 is linked to breast cancer.